Philips’ leadership in the rapid end-to-end treatment of stroke helping to improve patient outcomes and increase the efficiency of treatment Roy...
Agilent announced the signing of a Memorandum of Understanding (MOU) with the Sarawak Infectious Disease Centre (SIDC) in East Malaysia. The agreemen...
“Our ongoing partnership with Bayer leverages the full suite of our Twist Biopharma Solutions offering of antibody discovery services to identify the...
-Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, announced an extension ...
QIAGEN announced the launch of its QuantiFERON-EBV RUO (Research Use Only) assay. Epstein-Barr virus (EBV), or human herpes virus 4, is estimated in ...
Thailand Hub of Talents in Cancer Immunotherapy (TTCI), funded by the National Research Council of Thailand (NRCT), has been recently launched by ...
--Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management, announc...
QIAGEN announced the expansion of its clinical decision support software, QIAGEN Clinical Insight Interpret (QCI Interpret), to include artificial in...
“We know that our customers need to provide novel, reliable and consistent products to their consumers and patients,” said Angela Strzelecki, p...
MDxHealth SA (NASDAQ/Euronext: MDXH), a leading commercial-stage precision diagnostics company, today announced a research collaboration with the Universit...
Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of c...
Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the strategic r...
-Brain diagnostics innovator BrainScope announced a new investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in BrainScope’s ...
The primary objective is to evaluate VISTA as a biomarker to guide patient selection and treatment optimization for VISTA-targeted therapies where no stand...
© 2024 Biopharma Boardroom. All Rights Reserved.
